Matt Wiley

Matt Wiley currently serves as the Chief Commercial Officer at MindMed, a position held since March 2025. Prior to this role, Matt Wiley was the SVP, Chief Commercial Officer at BioXcel Therapeutics, Inc. from January 2022 to October 2024. From November 2018 to January 2022, Matt Wiley held the title of Chief Commercial Officer at VYNE Therapeutics. Additionally, from January 2012 to November 2018, Matt Wiley served as Vice President, Business Unit Lead for the Sleep division at Jazz Pharmaceuticals. Matt Wiley's earlier experience includes the role of Vice President of Marketing at Azur Pharma, Inc. from January 2007 to January 2012. Matt Wiley earned a Bachelor of Arts in English from Syracuse University, where studies took place from August 1990 to May 1994.